Three weeks post-infusion, the signs of orbital involvement had completely recovered (Fig. 2d), displaying the incredible ability of CD5-IL15/IL15sushi CAR T cells to ameliorate lymphoma-mediated CSF swelling. The gene discussed is CD5; the disease is lymphoma.